Edwards James M, Watson Nora, Focht Chris, Wynn Clara, Todd Christopher A, Walter Emmanuel B, Heine R Phillips, Swamy Geeta K
Maternal Fetal Medicine, WakeMed Health and Hospitals, Raleigh, NC, USA.
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC, USA.
Infect Dis Obstet Gynecol. 2019 Feb 3;2019:5430493. doi: 10.1155/2019/5430493. eCollection 2019.
Maternal GBS colonization is associated with early-onset neonatal sepsis and extensive efforts are directed to preventing this complication. Less is known about maternal risks of GBS colonization. We seek to provide a modern estimate of the incidence and impact of maternal GBS colonization and invasive GBS disease.
A single center historical cohort study of all births between 2003 and 2015 was performed. Data was collected via electronic health record abstraction using an institutional specific tool. Descriptive statistics were performed regarding GBS status. Inferential statistics were performed comparing risk of adverse pregnancy outcomes in cohorts with and without GBS colonization as well as cohorts with GBS colonization and invasive GBS disease.
A total of 60,029 deliveries were included for analysis. Overall, 21.6% of the population was GBS colonized and 0.1% had invasive GBS disease. GBS colonization was associated with younger maternal age, Black race, non-Hispanic ethnicity, chronic hypertension, preexisting diabetes, and tobacco use (p<0.01). In the adjusted analyses, there was an increased risk of gestational diabetes (aRR 1.21, 95% CI 1.11-1.32) in colonized pregnancies and a decreased incidence of short cervix (aRR 0.64, 95% CI 0.52-0.79), chorioamnionitis (aRR 0.76, 95% CI 0.66-0.87), wound infection (aRR 0.75, 95% CI 0.64-0.88), and operative delivery (aRR 0.85, 95% CI 0.83-0.88).
This modern-day large cohort of all births over a 12-year period demonstrates a GBS colonization rate of 21.6%. This data reflects a need to assess maternal and perinatal outcomes in addition to neonatal GBS sepsis rates to inform decisions regarding the utility of maternal vaccination.
孕产妇B族链球菌(GBS)定植与早发型新生儿败血症相关,人们为预防这一并发症付出了巨大努力。关于孕产妇GBS定植的风险,人们了解较少。我们旨在提供关于孕产妇GBS定植及侵袭性GBS疾病的发病率和影响的现代评估。
对2003年至2015年间所有分娩进行单中心历史队列研究。通过使用机构特定工具从电子健康记录中提取数据。对GBS状态进行描述性统计。进行推断性统计,比较有无GBS定植的队列以及有GBS定植和侵袭性GBS疾病的队列中不良妊娠结局的风险。
共纳入60,029例分娩进行分析。总体而言,21.6%的人群GBS定植,0.1%患有侵袭性GBS疾病。GBS定植与孕产妇年龄较小、黑人种族、非西班牙裔、慢性高血压、既往糖尿病和吸烟有关(p<0.01)。在调整分析中,定植妊娠发生妊娠期糖尿病的风险增加(调整后风险比[aRR]1.21,95%置信区间[CI]1.11 - 1.32),而宫颈短(aRR 0.64,95% CI 0.52 - 0.79)、绒毛膜羊膜炎(aRR 0.76,95% CI 0.66 - 0.87)、伤口感染(aRR 0.75,95% CI 0.64 - 0.88)和手术分娩(aRR 0.85,95% CI 范围 0.83 - 0.88)的发生率降低。
这一为期12年的现代大型全部分娩队列显示GBS定植率为21.6%。该数据表明,除了新生儿GBS败血症发生率外,还需要评估孕产妇和围产期结局,以便为孕产妇疫苗接种的效用决策提供依据。